U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06992258) titled 'Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer' on April 30.
Brief Summary: A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Intervention:
DRUG: Fruquintinib+ Lonsurf (trifluridine and tipiracil)
Experimental arm
DRUG: Fruquintinib
Standard Of Care Arm
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Criterium, Inc.
Publi...